Recovery Advocacy Warrior's Sarah Derigo and t County Health Department answer questions about Narcan. Also, see local overdose statistics.

Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...

A statement of intent about the regulation of kratom passed unanimously in a Tennessee House Judiciary committee meeting ...

The study, which was published in the journal Pharmacological Reports, analyzed the impact of four terpenes that are found in ...

The FDA approves a new non-opioid pain pill, Journavx, to treat acute pain in adults. It's a first-generation non-addictive ...

What you need to know about opioid overdose reversal drug nalmefene’s risks, effectiveness and clinical concerns ...

Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg, by Health Canada for the treatment of ...

Scientists at Medical University of Vienna, The University of Queensland and Universität Innsbruck have identified cysteine stapled dynorphin A (CSD) analogues acting as κ-opioid receptor antagonists ...

Terpenes from cannabis may relieve chronic pain without THC’s psychoactive effects. Researchers found that certain terpenes ...

The Scripps Research Institute has disclosed κ-opioid receptor antagonists reported to be useful for the treatment of depression, anxiety, schizophrenia, obesity, migraine, substance abuse and ...

"Most nitazene analogues encountered among the recreational drug supply retain opioid receptor activity and exhibit potency similar to or greater than that of fentanyl." DEA officials have ...

"It rapidly crosses the blood-brain barrier and binds opioid mu receptors, causing sedation, analgesia, respiratory depression and apnea. Respiratory depression and apnea lead to inadequate oxygen ...